Melanoma Vaccine Ushers in New Hope for Cancer Patientsnews2026-10-23T17:43:05+00:00October 23rd, 2026|The New York Times|
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Reportnews2026-10-22T20:01:09+00:00October 22nd, 2026|The New York Times|
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’news2026-10-09T20:26:29+00:00October 9th, 2026|The New York Times|
RFK Jr. Promised Children’s Health Reforms. Here’s How He Did.news2026-09-08T16:25:24+00:00September 8th, 2026|The New York Times|
A Guide to Covid, Flu and R.S.V. Vaccines This Fallnews2026-09-02T17:07:44+00:00September 2nd, 2026|The New York Times|
Can We Do Anything About Tick-Borne Diseases Like Alpha-Gal Syndrome?news2026-08-20T15:07:16+00:00August 20th, 2026|The New York Times|
Moderna’s Shift to Cancer Company Lifts Stock Up 177%news2026-08-20T14:23:51+00:00August 20th, 2026|The New York Times|
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returningnews2026-08-19T15:37:24+00:00August 19th, 2026|The New York Times|
A New Plan for Closer U.S.-Israel Military Cooperation, and the First mRNA Flu Vaccinenews2026-08-06T10:00:11+00:00August 6th, 2026|The New York Times|
F.D.A. Approves Moderna’s mRNA Flu Vaccinenews2026-08-06T02:24:28+00:00August 6th, 2026|The New York Times|
